Stockreport

Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings [Yahoo! Finance]

Praxis Precision Medicines, Inc.  (PRAX) 
PDF On February 17, 2026, Driehaus Capital Management disclosed a buy of 432,510 shares of Praxis Precision Medicines (NASDAQ:PRAX) , an estimated $80.54 million trade base [Read more]